Estimated read time: 7 minutes. Intended for laboratory researchers handling lyophilized peptides in non-human in vitro models. Not a clinical or human-use guide.
What “Reconstitution” Means in a Research Setting
Research peptides ship as lyophilized powder — freeze-dried, anhydrous, stable at refrigerated temperature for years when sealed. Reconstitution is the process of returning the powder to solution so it can be aliquoted, diluted, and added to an experimental system. The choice of diluent, the volume used, and the storage conditions afterward determine whether the peptide retains its specified purity through the working window of the experiment.
Choosing a Diluent
The two diluents used in nearly all research-peptide workflows are:
- Bacteriostatic water (BAC water) — sterile water containing 0.9% benzyl alcohol. The benzyl alcohol suppresses microbial growth, which extends the usable life of a multi-puncture vial. This is the standard choice for any peptide that will be sampled from the same vial more than once.
- Sterile water for injection (SWFI) — water without preservative. Appropriate for single-use applications or for compounds where benzyl alcohol could interfere with downstream assays.
Acetic-acid solutions are sometimes used for peptides with poor aqueous solubility (e.g. certain hydrophobic sequences). The peptide’s Certificate of Analysis or batch documentation indicates the correct diluent — review the COA Archive entry for your lot before reconstitution.
Standard Procedure
The following procedure applies to most lyophilized research peptides sold by AminoCore Labs — including BPC-157 5mg, TB-500 5mg, and Ipamorelin 5mg:
- Equilibrate the vial at room temperature for 15–20 minutes after removing it from refrigerated storage. Adding cold diluent to a cold vial encourages condensation inside the cap and increases denaturation risk.
- Wipe the rubber stopper with 70% isopropyl alcohol and allow it to air-dry. Do not puncture before the alcohol has evaporated.
- Draw the diluent into a sterile syringe. Volume depends on target concentration (see calculation below).
- Inject the diluent slowly down the wall of the vial, not directly onto the peptide cake. Direct stream impact on the powder causes mechanical shearing that can fragment longer peptide sequences.
- Swirl gently — never shake. Foaming is a sign of denaturation. If the powder does not dissolve within 60 seconds of swirling, allow the vial to rest at room temperature for an additional 5 minutes and swirl again.
- Inspect visually. The solution should be clear and colorless. Cloudiness, particulates, or precipitate indicate either a solubility problem with the chosen diluent or a compromised vial.
Calculating Working Concentration
Concentration after reconstitution is determined by the ratio of peptide mass to diluent volume. The formula is:
Concentration (mg/mL) = Peptide mass (mg) ÷ Diluent volume (mL)
Worked example: a 5 mg vial reconstituted with 2 mL of bacteriostatic water yields 2.5 mg/mL (or 2,500 mcg/mL). Drawing 0.1 mL of that solution into a working aliquot delivers 250 mcg of peptide.
Researchers working in dose-response panels typically reconstitute to a concentration that allows the smallest increment in the study to be drawn with a 1.0 mL syringe at no less than 0.05 mL — below that volume, syringe dead-space and measurement error become significant.
Storage After Reconstitution
Once a peptide is in solution, stability drops sharply compared to the lyophilized form. The following storage targets are conservative and applicable to most peptides in the AminoCore Labs catalog:
- Refrigerated, 2–8°C: 30 days maximum. The standard short-term storage window for reconstituted peptide stocks.
- Frozen, −20°C: Up to 3 months for most sequences. Aliquot before freezing — do not freeze the master vial. Repeated freeze-thaw cycles cause aggregation and purity loss.
- Light exposure: Store vials in cardboard or opaque containers. UV degrades certain residues (notably tryptophan and tyrosine).
For lyophilized vials that have not yet been reconstituted, refrigerated storage at 2–8°C is standard. Long-term storage at −20°C extends shelf life further but is not necessary if the material will be used within the stated COA window.
Common Stability Mistakes
- Shaking the vial after reconstitution. Mechanical agitation generates foam, which denatures peptide bonds at the air-liquid interface. Always swirl.
- Repeated freeze-thaw cycles on the master vial. Every cycle reduces effective concentration. Aliquot working volumes into single-use tubes before freezing.
- Storing reconstituted peptide at room temperature. Even bacteriostatic-water solutions lose potency rapidly above 8°C.
- Cross-contaminating diluent. Use a fresh sterile syringe for every vial. Carry-over between peptides can invalidate downstream assays.
- Ignoring the COA expiration window. The Certificate of Analysis lists a re-test date — material past that date should be re-verified, not assumed to be at the original purity.
Verifying Lot Purity Before You Begin
Before reconstituting, locate the Certificate of Analysis for the specific lot. AminoCore Labs publishes batch COAs in the public COA Archive; the lot number is printed on the vial label. The COA documents HPLC purity, residual solvents, and the test date. If you cannot locate a COA for your lot, contact us before running the experiment — lot traceability is a basic requirement for any peer-reviewable research result.
For more on what to look for in a COA, see our companion article: Understanding Peptide Purity & the Certificate of Analysis.
Lab Safety Notes
Treat every research peptide as a biologically active substance even when conventional toxicology data is absent. Standard PPE (gloves, eye protection, lab coat) applies. Sharps go in an approved biohazard container. Reconstitution should be done in a designated bench area, not at a shared workstation. Material safety information specific to a compound is available on request — contact our team for SDS documentation.
Disclaimer
FOR RESEARCH USE ONLY. The procedures described in this guide are intended exclusively for in vitro laboratory research in non-human models. AminoCore Labs research peptides are not intended for human consumption, veterinary use, diagnostic use, or any therapeutic application. None of the compounds discussed are approved by the FDA for use in humans. This article is informational reference material for laboratory professionals and does not constitute medical, veterinary, or clinical guidance.